Skip to main content
. 2023 Apr 18;12(4):613. doi: 10.3390/biology12040613

Figure 6.

Figure 6

Differential methylation analysis of ECT2 in tumor samples versus normal ones. (A) Tumors experienced higher methylation in the ECT2 promoter region in normal samples versus tumors as assessed by UALCAN analysis. (B) Analysis of CpG-aggregated methylation of ECT2 in a list of human tumors. ns: p > 0.05; *: p <= 0.05; **: p <= 0.01; ***: p <= 0.001; ****: p <= 0.0001.